Fr. 95.00

The Addiction Casebook

English · Paperback / Softback

Will be released 20.02.2014

Description

Read more

Klappentext The Addiction Casebook consists of 13 clinical cases that exemplify DSM-5 addiction diagnoses commonly encountered in clinical practice. Written in an engaging! easy-to-understand manner! the book complements substance abuse textbooks by providing hands-on experience with real-life situations and updated information relating to DSM-5(R) diagnoses. Zusammenfassung Presents 12 patients with DSM-5 addiction diagnoses - plus one experiencing problematic Internet use - and illustrates practical and successful strategies for diagnosing and treating these patients. The book's cases are analogous to those that clinicians commonly encounter in their everyday practice and effectively demonstrate the intersection of addiction with other psychiatric diagnoses. Introduction.; Moving from DSM-IV-TR to DSM-5.; Substance-related disorders.; Alcohol.; Caffeine.; Cannabis.; Hallucinogens.; Inhalants.; Opioids.; Sedatives, hypnotics, or anxiolytics.; Stimulants.; Tobacco.; Other (or unknown) substances.; Non-substance-related disorders.; Gambling.; Conditions for further study.; Internet.

Product details

Authors Petros Levounis, Petros (EDT)/ Herron Levounis
Assisted by Abigail J. Herron (Editor), Abigail J. (Director of Psychiatry Herron (Editor), Petros Levounis (Editor), Petros (Chair Levounis (Editor)
Publisher American Psychiatric Publishing
 
Languages English
Product format Paperback / Softback
Release 20.02.2014, delayed
 
EAN 9781585624584
ISBN 978-1-58562-458-4
No. of pages 210
Subject Natural sciences, medicine, IT, technology > Medicine > Clinical medicine

Customer reviews

No reviews have been written for this item yet. Write the first review and be helpful to other users when they decide on a purchase.

Write a review

Thumbs up or thumbs down? Write your own review.

For messages to CeDe.ch please use the contact form.

The input fields marked * are obligatory

By submitting this form you agree to our data privacy statement.